Board Meeting26 Mar 2026, 01:43 pm

Titan Biotech Ltd Closes Trading Window for Insider Trading Regulations

AI Summary

Titan Biotech Ltd has announced the closure of the trading window for dealing in the securities of the company. This closure is in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015 and the company's Code of Conduct for Prevention of Insider Trading. The closure is effective from Wednesday, 1st April 2026, and will remain in force until 48 hours after the declaration of the audited financial results for the financial year ending on 31st March 2026. The date of the Board Meeting for the approval of these results will be intimated in due course.

Key Highlights

Titan Biotech Ltd closes trading window in accordance with SEBI regulations and company's Code of Conduct
Closure effective from 1st April 2026
Will remain closed until 48 hours after the declaration of audited financial results for FY ending on 31st March 2026
Date of Board Meeting for approval of financial results to be intimated later
Trading window closure applies to all Designated Persons, their Immediate Relatives, and all Connected Persons covered under the Code

View BSE Filing

TITANBIO

Specialty Chemicals

TITAN BIOTECH LTD.

Price Impact